Time is precious

Low-volume dosing with NovoSeven® RT can help you get some of it back.


Active college student


Busy mother of 4


Husband, father, and pastor

Individual results may vary.

Less infusion 

NovoSeven® RT has 16× less infusion volume than pd-aPCCa

infusion time

NovoSeven® RT is up to 18× faster to infuse than pd-aPCCa

Start NovoSeven® RT

Experience fast bleed controlc with less volume and faster infusion time by enrolling in a free trial of NovoSeven® RT today.

Get Started

pd-aPCC=plasma-derived activated prothrombin complex concentrate.

aIndividual doses are compared and based on an 88-kg (194-lb) person receiving a single dose for a joint bleed.

bPeople are cautioned that the maximum injection or infusion rate must not exceed 2 units per kilogram of body weight per minute.

cBased on individual dosage for joint bleeds in patients with hemophilia A or B with and without inhibitors.

Indications and Usage

NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) is used for:

Important Safety Information


Warnings and Precautions

Side Effects

Use with Other Drugs

Please click here for NovoSeven® RT Prescribing Information

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch,
or call 1-800-FDA-1088.

NovoSeven® RT is a prescription medicine. Novo Nordisk provides patient assistance for those who qualify. Please call 1-877-NOVO-777 (1-877-668-6777) to learn more about Novo Nordisk assistance programs.